ChromaDex
(NASDAQ:CDXC)
$1.70
Last update: 12:45PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.67 - 1.7352 Wk Range1.15 - 4.03Open / Close1.7 / -Float / Outstanding66.4M / 74.5M
Vol / Avg.78.1K / 268.4KMkt Cap126.6MP/E-50d Avg. Price1.52
Div / Yield-Payout Ratio-Total Float66.4MEPS-0.01

ChromaDex Stock (NASDAQ:CDXC), Quotes and News Summary

ChromaDex Stock (NASDAQ: CDXC) stock price, news, charts, stock research, profile.

Loading...
Day Range1.67 - 1.7352 Wk Range1.15 - 4.03Open / Close1.7 / -Float / Outstanding66.4M / 74.5M
Vol / Avg.78.1K / 268.4KMkt Cap126.6MP/E-50d Avg. Price1.52
Div / Yield-Payout Ratio-Total Float66.4MEPS-0.01
Business Wire - Jun 1, 2022, 6:32AM
Seeking Alpha - Nov 16, 2022, 12:04PM
InvestorsObserver - Nov 3, 2022, 12:21PM
InvestorsObserver - Oct 4, 2022, 7:00AM
InvestorsObserver - Aug 11, 2022, 12:07PM
InvestorsObserver - Jun 17, 2022, 2:17PM
Sector: Health Care.Industry: Life Sciences Tools & Services
ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.060-0.040 0.0200
REV18.690M17.063M-1.627M
Q2 2022Est.ActualSurprise
EPS-0.080-0.090 -0.0100
REV18.650M16.732M-1.918M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy ChromaDex (CDXC) stock?

A

You can purchase shares of ChromaDex (NASDAQ: CDXC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ChromaDex's (CDXC) competitors?

Q

What is the target price for ChromaDex (CDXC) stock?

A

The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on Monday, August 29, 2022. The analyst firm set a price target for 5.50 expecting CDXC to rise to within 12 months (a possible 223.53% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ChromaDex (CDXC)?

A

The stock price for ChromaDex (NASDAQ: CDXC) is $1.7 last updated Today at November 28, 2022, 5:45 PM UTC.

Q

Does ChromaDex (CDXC) pay a dividend?

A

There are no upcoming dividends for ChromaDex.

Q

When is ChromaDex (NASDAQ:CDXC) reporting earnings?

A

ChromaDex’s Q3 earnings are confirmed for Wednesday, November 2, 2022.

Q

Is ChromaDex (CDXC) going to split?

A

There is no upcoming split for ChromaDex.

Q

What sector and industry does ChromaDex (CDXC) operate in?

A

ChromaDex is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.